Cipla and Boehringer Ingelheim to co-market three oral anti-diabetic drugs EP News Bureau Jun 29, 2020 The two companies will help co-market three anti-diabetic drugs Oboravo (Empagliflozin), Oboravo Met (Empagliflozin+Metformin) and…
